LACC Quality of Life Results with Michael Frumovitz

IJGC Podcast - A podcast by BMJ Group - Mondays

In this episode of the IJGC podcast, Dr. Pedro Ramirez interviews Dr. Michael Frumovitz about his recent publication in Lancet Oncology on the quality of life endpoints from the LACC trial. Tune in! You might be very surprised with their results!

Visit the podcast's native language site